Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Influenza, Human

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Influenza, Human in 2 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, L1
Li, R1
Pan, Y1
Chen, J1
Li, Y1
Wu, J1
Zhu, Y1
Lee, SM1
Gai, WW1
Cheung, TK1
Peiris, JS1

Other Studies

2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Influenza, Human

ArticleYear
High-throughput screen of protein expression levels induced by cyclooxygenase-2 during influenza a virus infection.
    Clinica chimica acta; international journal of clinical chemistry, 2011, May-12, Volume: 412, Issue:11-12

    Topics: Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Gene Expression Profiling; Gene Expression

2011
Antiviral activity of a selective COX-2 inhibitor NS-398 on avian influenza H5N1 infection.
    Influenza and other respiratory viruses, 2011, Volume: 5, Issue:Suppl 1

    Topics: Animals; Birds; Cell Culture Techniques; Cyclooxygenase Inhibitors; Humans; Influenza A Virus, H5N1

2011